메뉴 건너뛰기




Volumn 83, Issue 1, 2006, Pages 55-62

A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group study JCOG9203

(18)  Mizoroki, Fumi a,r   Hirose, Yuko b   Sano, Masayuki c   Fukuda, Haruhiko d   Tobinai, Kensei e   Nakata, Masanobu f   Taniwaki, Masafumi g   Kawano, Fumio h   Uozumi, Kimiharu i   Sawada, Kenichi j   Fukuhara, Shiro k   Nasu, Kaori l   Ohno, Yoichiro m   Toki, Hironobu n   Togawa, Atsushi o   Kikuchi, Masahiro p   Hotta, Tomomitsu q   Shimoyama, Masanori c  


Author keywords

Combination chemotherapy; Elderly patients; Non hodgkin's lymphoma; Phase II study

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE; VINDESINE;

EID: 31644439992     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05084     Document Type: Article
Times cited : (6)

References (32)
  • 1
    • 0025257248 scopus 로고
    • Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: Experience of the Non-Hodgkin's Lymphoma Pathologic Classification Project
    • Simon R, Durrleman S, Hoppe RT, et al. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the Non-Hodgkin's Lymphoma Pathologic Classification Project. Med Pediatr Oncol. 1990;18:89-96.
    • (1990) Med Pediatr Oncol , vol.18 , pp. 89-96
    • Simon, R.1    Durrleman, S.2    Hoppe, R.T.3
  • 2
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 5
    • 9444287115 scopus 로고    scopus 로고
    • A randomized controlled trial investigating the survival benefit of close-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002
    • Kinoshita T, Hotta T, Tobinai K, et al. A randomized controlled trial investigating the survival benefit of close-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002. Int J Hematol. 2004;80:341-350.
    • (2004) Int J Hematol , vol.80 , pp. 341-350
    • Kinoshita, T.1    Hotta, T.2    Tobinai, K.3
  • 6
    • 0023102508 scopus 로고
    • Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas: An analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma
    • Nanba K, Yamamoto H, Kamada N, et al. Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas: an analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma. Cancer. 1987;59: 1463-1469.
    • (1987) Cancer , vol.59 , pp. 1463-1469
    • Nanba, K.1    Yamamoto, H.2    Kamada, N.3
  • 7
    • 0019866936 scopus 로고
    • A new histological classification of malignant lymphomas (LSG classification) and its significance
    • Mikata A. A new histological classification of malignant lymphomas (LSG classification) and its significance. Nippon Ketsueki Gakkai Zasshi. 1981;44:1401-1410.
    • (1981) Nippon Ketsueki Gakkai Zasshi , vol.44 , pp. 1401-1410
    • Mikata, A.1
  • 8
    • 0018605304 scopus 로고
    • Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma: A proposal of a new type
    • Suchi T, Tajima K, Nanba K, et al. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma: a proposal of a new type. Acta Pathol Jpn. 1979;29:755-776.
    • (1979) Acta Pathol Jpn , vol.29 , pp. 755-776
    • Suchi, T.1    Tajima, K.2    Nanba, K.3
  • 9
    • 17444454475 scopus 로고
    • Toxicity grading criteria of the Japan Clinical Oncology Group: The Clinical Trial Review Committee of the Japan Clinical Oncology Group
    • Tobinai K, Kohno A, Shimada Y, et al. Toxicity grading criteria of the Japan Clinical Oncology Group: the Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol. 1993;23:250-257.
    • (1993) Jpn J Clin Oncol , vol.23 , pp. 250-257
    • Tobinai, K.1    Kohno, A.2    Shimada, Y.3
  • 10
    • 0003486931 scopus 로고
    • Geneva, Switzerland: World Health Organization; WHO offset publication No. 48
    • World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979. WHO offset publication No. 48.
    • (1979) WHO Handbook for Reporting Results of Cancer Treatment
  • 11
    • 0018866647 scopus 로고
    • Sample size considerations for non-randomized comparative studies
    • Makuch RW, Simon RM. Sample size considerations for non-randomized comparative studies. J Chronic Dis. 1980;33:175-181.
    • (1980) J Chronic Dis , vol.33 , pp. 175-181
    • Makuch, R.W.1    Simon, R.M.2
  • 13
    • 0025277237 scopus 로고
    • Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: A feasibility study using a mitoxantrone containing regimen
    • Sonneveld P, Michiels JJ. Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen. Br J Cancer. 1990;62:105-108.
    • (1990) Br J Cancer , vol.62 , pp. 105-108
    • Sonneveld, P.1    Michiels, J.J.2
  • 14
    • 0025865531 scopus 로고
    • Low-dose ACOP-B and VABE: Weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma
    • O'Reilly SE, Klimo P, Connors JM. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. J Clin Oncol. 1991;9:741-747.
    • (1991) J Clin Oncol , vol.9 , pp. 741-747
    • O'Reilly, S.E.1    Klimo, P.2    Connors, J.M.3
  • 15
    • 0027394689 scopus 로고
    • Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
    • Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993;328: 1002-1006.
    • (1993) N Engl J Med , vol.328 , pp. 1002-1006
    • Fisher, R.I.1    Gaynor, E.R.2    Dahlberg, S.3
  • 16
    • 20344362405 scopus 로고    scopus 로고
    • Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma
    • Mori M, Kitamura K, Masuda M, et al. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. Int J Hematol. 2005;81:246-254.
    • (2005) Int J Hematol , vol.81 , pp. 246-254
    • Mori, M.1    Kitamura, K.2    Masuda, M.3
  • 17
    • 0004815869 scopus 로고    scopus 로고
    • CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
    • Tirelli U, Errante D, van Glabbeke M. et al. CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol. 1998;16:27-34.
    • (1998) J Clin Oncol , vol.16 , pp. 27-34
    • Tirelli, U.1    Errante, D.2    Van Glabbeke, M.3
  • 18
    • 0034985710 scopus 로고    scopus 로고
    • Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma
    • Mori M, Niitsu N, Takagi T, et al. Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma. Leuk Lymphoma. 2001;41:359-366.
    • (2001) Leuk Lymphoma , vol.41 , pp. 359-366
    • Mori, M.1    Niitsu, N.2    Takagi, T.3
  • 19
    • 0037165261 scopus 로고    scopus 로고
    • CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
    • Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-242.
    • (2002) N Engl J Med , vol.346 , pp. 235-242
    • Coiffier, B.1    Lepage, E.2    Briere, J.3
  • 20
    • 0037295169 scopus 로고    scopus 로고
    • A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma
    • Bessell EM, Burton A, Haynes AP, et al. A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma. Ann Oncol. 2003;14:258-267.
    • (2003) Ann Oncol , vol.14 , pp. 258-267
    • Bessell, E.M.1    Burton, A.2    Haynes, A.P.3
  • 21
    • 0038603184 scopus 로고    scopus 로고
    • CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: Results of a Nordic Lymphoma Group randomized trial
    • Osby E, Hagberg H, Kvaloy S, et al. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood. 2003;101:3840-3848.
    • (2003) Blood , vol.101 , pp. 3840-3848
    • Osby, E.1    Hagberg, H.2    Kvaloy, S.3
  • 22
    • 0042914721 scopus 로고    scopus 로고
    • CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
    • Doorduijn JK, van der Halt B, van Imhoff GW, et al. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2003;21:3041-3050.
    • (2003) J Clin Oncol , vol.21 , pp. 3041-3050
    • Doorduijn, J.K.1    Van Der Halt, B.2    Van Imhoff, G.W.3
  • 23
    • 3242802160 scopus 로고    scopus 로고
    • Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL
    • Pfreundschuh M, Trumper L, Kloess M, et al, and the German High-Grade Non-Hodgkin's Lymphoma Study Group. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood. 2004;104:634-641.
    • (2004) Blood , vol.104 , pp. 634-641
    • Pfreundschuh, M.1    Trumper, L.2    Kloess, M.3
  • 24
    • 0033168330 scopus 로고    scopus 로고
    • Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients
    • Zinzani PL, Storti S, Zaccaria A, et al. Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood. 1999;94:33-38.
    • (1999) Blood , vol.94 , pp. 33-38
    • Zinzani, P.L.1    Storti, S.2    Zaccaria, A.3
  • 25
    • 10744224285 scopus 로고    scopus 로고
    • Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
    • Tilly H, Lepage E, Coiffier B, et al. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood. 2003; 102:4284-4289.
    • (2003) Blood , vol.102 , pp. 4284-4289
    • Tilly, H.1    Lepage, E.2    Coiffier, B.3
  • 27
    • 20444500958 scopus 로고    scopus 로고
    • A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: Prognostic impact independent of International Prognostic Index
    • Janssen-Heijnen, van Spronsen DJ, Lemmens VE, Houterman S, Verheij KD, Coebergh JW. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol. 2005;129:597-606.
    • (2005) Br J Haematol , vol.129 , pp. 597-606
    • Janssen-Heijnen1    Van Spronsen, D.J.2    Lemmens, V.E.3    Houterman, S.4    Verheij, K.D.5    Coebergh, J.W.6
  • 28
    • 0345490987 scopus 로고    scopus 로고
    • Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: Systematic review and meta-analysis
    • Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723-1732.
    • (2003) Gastroenterology , vol.125 , pp. 1723-1732
    • Gisbert, J.P.1    Garcia-Buey, L.2    Pajares, J.M.3    Moreno-Otero, R.4
  • 29
    • 10744224509 scopus 로고    scopus 로고
    • Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: A Japan Clinical Oncology Group Study, JCOG9301
    • Takenaka T, Ho K, Suzuki T, et al. Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan Clinical Oncology Group Study, JCOG9301. Int J Hematol. 2004;79:165-173.
    • (2004) Int J Hematol , vol.79 , pp. 165-173
    • Takenaka, T.1    Ho, K.2    Suzuki, T.3
  • 30
    • 0030067985 scopus 로고    scopus 로고
    • Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
    • Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet. 1996;347:92-93.
    • (1996) Lancet , vol.347 , pp. 92-93
    • Vento, S.1    Cainelli, F.2    Mirandola, F.3
  • 31
    • 0032530425 scopus 로고    scopus 로고
    • Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies
    • Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer. 1998;83: 1224-1230.
    • (1998) Cancer , vol.83 , pp. 1224-1230
    • Zuckerman, E.1    Zuckerman, T.2    Douer, D.3    Qian, D.4    Levine, A.M.5
  • 32
    • 0032719594 scopus 로고    scopus 로고
    • Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy: A prospective study in 305 patients
    • Markovic S, Drozina G, Vovk M, Fidler-Jenko M. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy: a prospective study in 305 patients. Hepatogastroenterology. 1999;46:2925-2930.
    • (1999) Hepatogastroenterology , vol.46 , pp. 2925-2930
    • Markovic, S.1    Drozina, G.2    Vovk, M.3    Fidler-Jenko, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.